2Alyea EP, Kim HT, Ho V, et al. Comparative outcome of nonmye- loablative and myeloablative allogeneic hematopoietic cell trans- plantation for patients older than 50 years of age [ J 1. Blood, 2005,105(4) :1810-1814.
3Hari P, Carreras J, Zhang M J, et al. Allogeneic transplants in follicular lymphoma: higher risk of disease progression after re- duced-intensity compared to myeloablative conditioning E J 1. Biol Blood Marrow Transplant,2008, 14 (2) :236-245.
4Rodriguez R, Nademanee A, Ruel N, et al. Comparison of Re- duced-intensity and conventional myeloablative regimens for alloge- neie transplantation in non-Hodgkin' s lymphoma [ J ]. Biol Blood Marrow Transplant, 2006, 12 (12) : 1326-1334.
5Kim I, Lee KH, Choi Y, et al. Allogeneic stem cell transplanta- tion for patients with advanced hematological malignancies: com- parison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning E J]. J Korean Med Sci, 2007, 22: 227-234.
6Tomblyn M, Brunstein C, Burns LJ, et al. Similar and promising outcomes in lymphoma patients treated with myeloablative or non- myeloablative conditioning and allogeneic hematopoietic cell trans- plantationl J ]. Biol Blood Marrow Transplant, 2008, 14 ( 5 ) : 538-545.
7Pifiana JL, Martino R, Gayoso J, et al. Reduced intensity condi- tioning HLA identical sibling donor allogeneie stem cell transplan- tation for patients with follicular lymphoma: long-term follow-up from two prospective muhicenter trials [ J ]. Haematologica, 2010, 95(7) :1176-82.
8Rezvani AR, Storer B, Maris M, et al. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent Non-Hodgkin' s lympboma[ J]. J Clin Oneol, 2008, 10;26(2) :211-217.
9Ingram W, Devereux S, Das-Gupta EP,et al. Outcome of BEAM- autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma [ J ]. Br J Haematol, 2008,141 (2) :235-243.
10Gopal AK, Pagel JM, Rajendran JG, et al. improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy[ J]. Biol Blood Marrow Transplant,2006, 12 (7) :697-702.
